Researchers at Providence Portland Medical Center are approved to begin a special vaccine trial for COVID-19. The trial will take place through the Providence Cancer Institute. Doctors say this particular vaccine incorporates immunotherapy that has been developed over the last three decades at the Earle A. Chiles Research Institute, and is tailored for older adults. The trial’s initial phase involves 36 volunteers, with half of the subjects between the ages of 18 and 50.